Back to Driehaus Capital Management LLC Driehaus Capital Management LLC

CYTKCYTK

Showing 0 of 19 quarters

Position history for Driehaus Capital Management LLCDriehaus Capital Management LLC's holdings in Cytokinetics, Incorporated

No. Driehaus Capital Management exited its CYTK (Cytokinetics) position in Q1 2024. Its Q4 2023 13F listed 220,384 shares worth $18.4M. Driehaus Capital Management first reported CYTK in Q2 2019 and held it in 17 quarterly 13F filings.

Current Value

—

Current Shares

—

Total Value Change

$0

Total Shares Change

0

No position history available for this security.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used